News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rubin Eyal
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Rubin Eyal (Sr. VP and CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 201,903 shares
@ $0 |
|
| 09/09/2022 |
4
| Rubin Eyal (Sr. VP and CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $1.03, valued at
$360.5k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4/A
| Rubin Eyal (Sr. VP and CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 246,146 shares
@ $0 |
|
| 08/13/2020 |
4
| Rubin Eyal (Sr. VP and CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 246,146 shares
@ $0 |
|
| 09/24/2019 |
4
| Rubin Eyal (Sr. VP & CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 800,000 options to buy
@ $0.2, valued at
$160k
|
|
| 09/24/2019 |
3
| Rubin Eyal (Sr. VP & CFO) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 11/20/2017 |
4
| Rubin Eyal (CFO and Treasurer) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 25,000 shares
@ $0
Granted 93,686 options to buy
@ $4.3, valued at
$402.8k
|
|
| 11/20/2017 |
3
| Rubin Eyal (CFO and Treasurer) has filed a Form 3 on BRAINSTORM CELL THERAPEUTICS INC. |
|
|